Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 10, 2025Indian Journal of OphthalmologyOpen Access

Central serous chorioretinopathy imaging biomarkers as potential indicators of response to subthreshold nanosecond laser

View Full Paper
Ask AI
Bookmark
Share

Authors

VBVesna BosicDFDoris FraenkelHMHajra Mudassar

Discussion

Loading...

Member takes

Overview

Retrospective study evaluates OCT and ICGA biomarkers, indicating treatment response in cCSC patients.

Key Points

  • Higher IVA rates significantly predicted poor response after initial nanosecond laser treatment.
  • OCT and ICGA biomarkers indicated response to treatment in chronic central serous chorioretinopathy patients.
  • Patients with IVA at baseline had a statistically greater need for multiple nanosecond laser sessions.
  • Observation of anatomical changes was tied to optical coherence tomography and indocyanine green angiography findings.

Cite This Study

Bosic et al. (2025) studied this question.

synapsesocial.com/papers/68c1d7f654b1d3bfb60fa073https://doi.org/10.4103/ijo.ijo_450_25
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Subthreshold micropulse 520-nm laser for acute central serous chorioretinopathy: short-term outcomes and structural OCT biomarkers2026
  2. 2Quantitative choroidal evaluation after subthreshold micropulse laser in chronic central serous chorioretinopathy using ultrawide-field SS-OCTA2026
  3. 3Efficacy of 577 nm subthreshold micropulse laser in central serous chorioretinopathy2024
  4. 4Short-Term Outcomes of Combined Anti-VEGF and Laser Photocoagulation in Chronic Central Serous Chorioretinopathy2025
  5. 5Comparison of the efficacy of subthreshold micropulse laser versus intravitreal anti-VEGF therapy for chronic central serous chorioretinopathy2026